| Model Number |
TRB24-REG |
| Medical Device Problem Code |
Deflation Problem (1149)
|
| Health Effect - Clinical Code |
Hematoma (1884)
|
| Date of Event |
01/05/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A1: patient identifier: requested, not provided due to hospital policy a2: age & date of birth: requested, not provided due to hospital policy a3a: sex: requested, not provided due to hospital policy a4: weight: requested, not provided due to hospital policy a5: ethnicity: requested, not provided due to hospital policy a6: race: requested, not provided due to hospital policy d6a: implanted date: device was not implanted d6b: explanted date: device was not explanted e3: occupation: cardiac cath lab manager / rn the actual device is not available for return.The investigation is currently ongoing.A follow-up report will be submitted once the investigation is complete.
|
| |
|
Event or Problem Description
|
|
Terumo medical corporation received the following reported information: percutaneous coronary intervention via radial access using a 6 french glidesheath slender sheath.The patient began to develop hematoma following conclusion of procedure and placement of the tr band.The tr band was placed per protocol and instruction for use (ifu).The balloon deflated prematurely and blood appeared.The tr band was re-inflated for hemostasis.The patient showed hematoma symptoms upon reaching post-procedural room & care.Procedure was deemed successful.There was no blood loss.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being sent as follow-up no.1 to provide the completed investigation results.The actual device was not returned; therefore, an evaluation of the actual device was unable to be conducted.The complaint cannot be confirmed for air leakage issues because a sample was not returned for assessment.Without a sample, the exact root cause cannot be determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with terumo medical corporation specifications and procedures and the device was released in a conforming state.Currently, no action is recommended since the risk evaluation is within the predetermined limits in the hazard based risk table (hbrt).
|
| |
|
Search Alerts/Recalls
|